Time is of the Essence: A Response to “Impact of Ventricular Assist Device Use on Pediatric Heart Transplant Waitlist Mortality: Analysis of the Scientific Registry of Transplant Recipients Database”
This article relates to:
-
Impact of ventricular assist device use on pediatric heart transplant waitlist mortality: Analysis of the scientific registry of transplant recipients database
- Volume 28Issue 4Pediatric Transplantation
- First Published online: May 20, 2024
Avital Ludomirsky
Division of Cardiology, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA
Department of Pediatrics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA
Search for more papers by this authorCorresponding Author
Jonathan B. Edelson
Division of Cardiology, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA
Department of Pediatrics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA
Leonard Davis Institute of Health Economics, The University of Pennsylvania, Philadelphia, Pennsylvania, USA
Cardiovascular Outcomes, Quality, and Evaluative Research Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA
Correspondence:
Jonathan B. Edelson ([email protected])
Search for more papers by this authorAvital Ludomirsky
Division of Cardiology, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA
Department of Pediatrics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA
Search for more papers by this authorCorresponding Author
Jonathan B. Edelson
Division of Cardiology, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA
Department of Pediatrics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA
Leonard Davis Institute of Health Economics, The University of Pennsylvania, Philadelphia, Pennsylvania, USA
Cardiovascular Outcomes, Quality, and Evaluative Research Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA
Correspondence:
Jonathan B. Edelson ([email protected])
Search for more papers by this authorOpen Research
Data Availability Statement
The authors have nothing to report.
References
- 1A. I. Dipchand, R. Kirk, D. C. Naftel, et al., “Ventricular Assist Device Support as a Bridge to Transplantation in Pediatric Patients,” Journal of the American College of Cardiology 72 (2018): 402–415.
- 2M. M. Colvin, J. M. Smith, Y. S. Ahn, et al., “ Organ Procurement and Transplantation Network (OPTN) and Scientific Registry of Transplant Recipients (SRTR),” in OPTN/SRTR 2022 Annual Data Report (U.S. Department of Health and Human Services, Health Resources and Services Administration, 2024). http://srtr.transplant.hrsa.gov/annual_reports/Default.aspx.
- 3R. J. Williams, M. Lu, L. A. Sleeper, et al., “Pediatric Heart Transplant Waiting Times in the United States Since the 2016 Allocation Policy Change,” American Journal of Transplantation 22 (2022): 833–842.
- 4F. Zafar, C. Castleberry, M. S. Khan, et al., “Pediatric Heart Transplant Waiting List Mortality in the Era of Ventricular Assist Devices,” The Journal of Heart and Lung Transplantation 34 (2015): 82–88.
- 5A. Butto, L. K. Wright, J. Dyal, C. Y. Mao, R. Garcia, and W. T. Mahle, “Impact of Ventricular Assist Device Use on Pediatric Heart Transplant Waitlist Mortality: Analysis of the Scientific Registry of Transplant Recipients Database,” Pediatric Transplantation 28, no. 4 (2024): e14787.
- 6N. Uriel, P. C. Colombo, J. C. Cleveland, et al., “Hemocompatibility-Related Outcomes in the MOMENTUM 3 Trial at 6 Months: A Randomized Controlled Study of a Fully Magnetically Levitated Pump in Advanced Heart Failure,” Circulation 135 (2017): 2003–2012.
- 7C. J. VanderPluym, R. S. Cantor, D. Machado, et al., “Utilization and Outcomes of Children Treated With Direct Thrombin Inhibitors on Paracorporeal Ventricular Assist Device Support,” ASAIO Journal 66 (2020): 939–945.
- 8J. Conway, S. Amdani, D. L. S. Morales, et al., “Widening Care gap in VAD Therapy,” The Journal of Heart and Lung Transplantation 42 (2023): 1710–1724.
- 9D. M. Peng, R. R. Davies, K. E. Simpson, et al., “Seventh Annual Society of Thoracic Surgeons Pedimacs Report,” The Annals of Thoracic Surgery 117 (2024): 690–703.
- 10B. B. Das, C. T. Blackshear, S. T. Lirette, et al., “Impact of 2016 UNOS Pediatric Heart Allocation Policy Changes on VAD Utilization, Waitlist, and Post-Transplant Survival Outcomes in Children With CHD Versus Non-CHD,” Clinical Transplantation 37 (2023): e14843.
- 11A. Lorts and E. D. Blume, “Pediatric Mechanical Circulatory Support: Available Devices and Outcomes as Bridge-To-Transplant Therapy,” Current Opinion in Organ Transplantation 20 (2015): 557–561.
- 12L. C. Jordan, R. N. Ichord, O. Reinhartz, et al., “Neurological Complications and Outcomes in the Berlin Heart EXCOR(R) pediatric Investigational Device Exemption Trial,” Journal of the American Heart Association 4 (2015): e001429.
